Holy Stone Healthcare Co (ROCO:4194) Altman Z-Score: N/A (As of Jul. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4194 Holy Stone Healthcare Co Ltd ROCO:4194
45 GF Score
Price NT$6.99
GF Value NT$3.93
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Holy Stone Healthcare Co Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Holy Stone Healthcare Co has a Altman Z-Score of N/A, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Holy Stone Healthcare Co's Altman Z-Score or its related term are showing as below:

During the past 13 years, Holy Stone Healthcare Co's highest Altman Z-Score was 22.55. The lowest was 0.55. And the median was 13.44.


Holy Stone Healthcare Co  (ROCO:4194) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Holy Stone Healthcare Co Altman Z-Score Related Terms


Holy Stone Healthcare Co Altman Z-Score Historical Data

* Premium members only.

The historical data trend for Holy Stone Healthcare Co's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Holy Stone Healthcare Co Altman Z-Score Chart

Holy Stone Healthcare Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.67 22.55 0.55 13.44 0.00

Holy Stone Healthcare Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.55 0.00 13.44 0.00 0.00

ROCO:4194 vs VRTX, REGN, ALNY: Altman Z-Score Comparison

For the Biotechnology subindustry, Holy Stone Healthcare Co's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Holy Stone Healthcare Co Altman Z-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Holy Stone Healthcare Co's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Holy Stone Healthcare Co's Altman Z-Score falls into.


ROCO:4194
45GF Score
Holy Stone Healthcare Co Ltd ROCO:4194
Altman Z-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Holy Stone Healthcare Co Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Holy Stone Healthcare Co's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.6066+1.4*-5.8015+3.3*-0.5036+0.6*27.0825+1.0*0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2025:
Total Assets was NT$220.52 Mil.
Total Current Assets was NT$164.95 Mil.
Total Current Liabilities was NT$31.19 Mil.
Retained Earnings was NT$-1,279.34 Mil.
Pre-Tax Income was NT$-111.32 Mil.
Interest Expense was NT$-0.26 Mil.
Revenue was NT$0.00 Mil.
Market Cap (Today) was NT$1,020.36 Mil.
Total Liabilities was NT$37.68 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(164.948 - 31.191)/220.518
=0.6066

X2=Retained Earnings/Total Assets
=-1279.338/220.518
=-5.8015

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-111.32 - -0.258)/220.518
=-0.5036

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=1020.361/37.676
=27.0825

X5=Revenue/Total Assets
=0/220.518
=0

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Holy Stone Healthcare Co has a Altman Z-Score of N/A indicating it is in Distress Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.

Is Holy Stone Healthcare Co (ROCO:4194) Overvalued in 2026?

Based on GuruFocus' analysis, Holy Stone Healthcare Co stock appears to be overvalued. The current stock price of NT$6.99 is trading 77.9% above its estimated GF Value™ of NT$3.93. GuruFocus considers Holy Stone Healthcare Co to be Significantly Overvalued.

Key valuation signals for ROCO:4194:

  • Altman Z-Score: N/A
  • GF Value™: NT$3.93 vs. price of NT$6.99 (77.9% above fair value)
  • GF Score™: 45/100 with 2 warning signs

No single metric tells the full story. See the ROCO:4194 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Holy Stone Healthcare Co Business Description

Address Number 88, Section 1, Neihu Road, 4th Floor, Neihu District, Taipei, TWN, 11493
Holy Stone Healthcare Co Ltd is a Taiwan based company focused on a biopolymer drug delivery platform. It is involved in the development of new drugs and medical devices, especially hyaluronic acid related therapeutic products. The products of the company include RenehaVis, SportVis, TRUD, and GAF.
45GF Score

Get the complete analysis for ROCO:4194

Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$6.99
Price
NT$3.93
GF Value